Back to news
BUSINESSThe Marijuana Herald

Mile High Labs files FDA drug master file for CBD isolate

Colorado-based Mile High Labs filed a Type II Drug Master File for its 98% CBD isolate, enabling pharmaceutical developers to reference confidential manufacturing and quality information in their own FDA submissions. The filing is not FDA approval, but it shows a regulatory pathway Oklahoma cannabinoid manufacturers may need to evaluate when supplying pharmaceutical programs.

Share this update

FacebookXLinkedInEmail

#national#colorado#hemp#compliance#manufacturing#pharmaceuticals

Read the original source

Leafy summaries provide industry context. Confirm details with The Marijuana Herald.

Open source

Continue reading

Related industry updates